Clinical Trial

Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea

Study acronym: OSA/MAFLD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Association between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-16.
Trial Details
NCT Number NCT07716995
Lead Sponsor Assiut University
Conditions Obstructive Sleep Apnea, Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment 127 participants
Start Date 2026-08-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22